China Securities Journal has reported that regulatory authorities in mainland China have recently issued guidance aimed at curbing the sale of insurance asset management products to individual investors. The guidance reportedly urges insurance asset management companies to limit the scale of investment in such products by individual investors and suggests refraining from issuing new insurance asset management products specifically targeted at individual investors.
According to the report, insurance fund managers have confirmed receiving indications from industry sources about this directive. However, some insurance fund managers have downplayed the potential impact of the regulatory adjustment. They assert that while restrictions may be imposed on insurance asset management products, individual investors still have alternative avenues to participate in the asset management market. Notably, individual investors can continue to access wealth management products offered by insurers.
The move by regulatory authorities to restrict the sale of insurance asset management products to individual investors signals a proactive stance toward regulating the investment landscape. Despite concerns raised by industry insiders, the overall impact of these measures remains subject to ongoing observation and analysis.
